PTC Therapeutics develops and markets prescription drugs, including Sephience and Emflaza, for patients treated by doctors. It last closed at $56.42 on Nov 20, down 3.27% on the day. The next earnings report for PTCT is expected around Mon, Jan 11, 2027, after the close. For the quarter ended Sep 2026, PTCT reported EPS of -$0.62 on revenue of $357.8M, with revenue up 69.6% from a year ago. Over its last 8 reports the stock moved an average of 7.9% the session after earnings. Over the last 12 months PTCT insiders bought $0 of stock on the open market and sold $56.2M, according to SEC Form 4 filings.
AI Auto Pilots
Is PTCT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PTCT.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on PTCTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
PTCT · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 11% below its 20 day and 12% below its 50 day average. It is 24% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 34), near oversold. The nearest support is the 52 week low at $56.18, and the nearest resistance the Pivot at $57.19.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 4.3%/day
Key levels
$90.8752 week high+61.1%
$69.79200 day average+23.7%
$68.95100 day average+22.2%
$63.74Swing high (Oct 21)+13.0%
$63.2650 day average+12.1%
$62.8520 day average+11.4%
$58.19Pivot R1+3.1%
$57.19Pivot+1.4%
$56.42Last close
$56.1852 week low−0.4%
$55.41Pivot S1−1.8%
Indicators
RSI (14)
33.59
Weak, oversold below 30
Neutral
MACD
-1.25
Below its signal line
Bearish
Stochastic
5.1
Near the bottom of its range
Oversold
ADX (14)
17.2
No clear trend
Williams %R
-98.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-161.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−13.8%
Change over 10 sessions
Bearish
ATR (14)
$2.45
Typical daily range, 4.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, nearing oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 10.8%/day
Key levels
$90.8752 week high+61.1%
$69.79200 day average+23.7%
$68.95100 day average+22.2%
$63.74Swing high (Oct 21)+13.0%
$63.2650 day average+12.1%
$62.8520 day average+11.4%
$58.19Pivot R1+3.1%
$57.19Pivot+1.4%
$56.42Last close
$56.1852 week low−0.4%
$55.41Pivot S1−1.8%
Indicators
RSI (14)
36.94
Weak, oversold below 30
Neutral
MACD
-3.17
Below its signal line
Bearish
Stochastic
23.8
Middle of its range
Neutral
ADX (14)
18.9
No clear trend
Williams %R
-98.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-115.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−14.6%
Change over 10 sessions
Bearish
ATR (14)
$6.09
Typical daily range, 10.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for PTCT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how PTCT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow PTCT usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for PTCTHow many large options trades hit PTCT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in PTCT in the last 90 days.
From SEC Form 4 filings by PTCT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PTCT is in one of them and how their past PTCT trades turned out.
PTC Therapeutics is a pharmaceutical company based in Warren, New Jersey. It develops and markets prescription drugs, including Sephience and Emflaza, and its products are often for conditions that affect a small number of patients. Sales depend heavily on coverage and reimbursement from government programs such as Medicare and Medicaid and from private insurers, as well as on physician prescribing.